CLOs on the Move

Nimbus Therapeutics

www.nimbustx.com

 
Nimbus Therapeutics is a biotechnology company headquartered in Cambridge, Massachusetts (USA).
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million
  • www.nimbustx.com
  • 784 Memorial Drive Suite 100
    Cambridge, MA USA 02139
  • Phone: 857.999.2009

Executives

Name Title Contact Details
Zak Huang
Vice President, Regulatory Affairs, and Gabrielle Poirier as Vice President, Clinical Operations Profile

Similar Companies

Highline Sciences

Highline Sciences is a specialized, full-service CRO and consultancy founded from within an oncology biotech to provide a better solution. We understand the gap between what you need and what you get from a traditional CRO and we’re here to improve the...

Lysogene

Lysogene is a biopharmaceutical gene therapy company with lead programs in neurodegenerative lysosomal storage disorders that affect children. Founded in 2009 by Karen Aiach, whose own child was affected by a neurodegenerative disease, Lysogene is rooted in a deep and compassionate understanding of the impact these diseases have on patients and families. Karen`s personal experience fuels her determination to deliver real solutions that will improve patient outcomes and enhance quality of life for both patients and caregivers. Over the past 10 years, Lysogene has acquired deep experience in developing gene therapies—from early discovery through the clinical, registration and review phases. Our strong science and execution track record has been validated by our partnership with Sarepta Therapeutics and the support of top-tier investors, with nearly $100m raised since inception.

Gen Trak (Main)

Gen Trak (Main) is a Liberty, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Moderna

Learn how we’re changing the world of medicine. Discover career opportunities, our product pipeline, and browse media resources. Meet Moderna.

Carmell Therapeutics

Our groundbreaking plasma-based materials are designed to improve patient outcomes and reduce healthcare costs across a variety of surgical procedures.